ImmunologybioRxivPreprint
Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates
J. I. Moliva, S. F. Andrew, B. J. Flynn…·Nason
This study shows a gorilla adenovirus-based vaccine provides durable immunity against SARS-CoV-2 in both airways of non-human primates, with enhanced protection from aerosol delivery and prime-boost regimens.
DOI 10.1101/2023.11.22.567930